Previous 10 | Next 10 |
Gainers: NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...
Medley Management (NYSE: MDLY ) +35% as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...
NovaBay (NYSEMKT: NBY ): Q2 revenue of $1.8M (-39.0% Y/Y) beats by $0.27M . The company will report its 2Q19 results on 8th August, 2019. Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,
Company to hold second quarter 2019 conference call on August 8 NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports net sales of $1.8 million for the three months...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that President and CEO Justin Hall has issued the following letter to stockholders: To My Fellow Stockholders: ...
Infrastructure and Energy Alternatives (NASDAQ: IEA ) +24% . on announcing two new wind energy project awards valued at ~$150M. More news on: Infrastructure and Energy Alternatives, Inc., NeoPhotonics Corporation, Pareteum Corporation, Stocks on the move, Read more ...
Infrastructure and Energy Alternatives (NASDAQ: IEA ) +24% . on announcing two new wind energy project awards valued at ~$150M. More news on: Infrastructure and Energy Alternatives, Inc., NeoPhotonics Corporation, Pareteum Corporation, Stocks on the move, Read more ...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that the New York Stock Exchange (NYSE) has accepted the Company’s plan to regain compliance with the NYSE...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that the New York Stock Exchange (NYSE) has accepted the Company’s plan to regain compliance with the NYSE...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces the closing of a private placement of common stock and warrants with accredited investors, raising gross procee...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...